<-- test --!> Health and Fitness – Page 741 – Best Reviews By Consumers

Health and Fitness

Ask the Pediatrician: When a pet dies, how do I help my child cope?

by Dr. Dipesh Navsaria, American Academy of Pediatrics Credit: Unsplash/CC0 Public Domain How your child reacts to your pet’s death will depend on their age and developmental level. When children display emotions like sadness, it’s important to validate them. During my own childhood, I remember when a pet died, my well-meaning mother told me I …

Ask the Pediatrician: When a pet dies, how do I help my child cope? Read More »

Putting a price on exoskeleton assistance puts users in the driver’s seat of honing the tech

How much would these robo-boots be worth to you? Credit: Neurobionic Lab/University of Michigan Robotics Department, CC BY-ND My colleagues and I have used a tool from economics to measure the costs and benefits of wearing an exoskeleton, and we found that it offers a modest average benefit of US$3.40 per hour while walking uphill, …

Putting a price on exoskeleton assistance puts users in the driver’s seat of honing the tech Read More »

Rare dialysis complication can kill, and more could be done to stop it

Credit: Unsplash/CC0 Public Domain Nieltje Gedney was half-asleep in her West Virginia home, watching murder mysteries over the hum of a bedside hemodialysis machine, when she felt something warm and wet in her armpit. A needle inserted into her arm had fallen loose, breaking a circuit that the machine used to clean her blood. It …

Rare dialysis complication can kill, and more could be done to stop it Read More »

Bayer expands Radiology Business into AI Market with Calantic™ Digital Solutions

Berlin, June 28, 2022 – Bayer today announced the launch of Calantic™ Digital Solutions, a new platform delivering access to digital applications, including artificial intelligence (AI) enabled programs for medical imaging. The offering contains tools which aid radiologists and their teams to improve prioritization, lesion detection, quantification, and productivity. By providing access to AI radiology …

Bayer expands Radiology Business into AI Market with Calantic™ Digital Solutions Read More »

Vividion Therapeutics names Aleksandra Rizo as President and Head of Research and Development

SAN DIEGO – June 23, 2022 – Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, and a wholly owned and independently operated subsidiary of Bayer AG, today announced that Aleksandra Rizo, M.D., Ph.D., will join the company …

Vividion Therapeutics names Aleksandra Rizo as President and Head of Research and Development Read More »

Rivaroxaban (Xarelto™) approved in Japan for patients with peripheral artery disease (PAD) after revascularisation

Berlin, June 21, 2022 – The Ministry of Health, Labor and Welfare in Japan has approved the use of the oral Factor Xa inhibitor rivaroxaban (Xarelto™) (2.5 mg twice daily, used in combination with aspirin 81-100 mg once daily) to treat patients with peripheral artery disease (PAD) after revascularization. The approval is based on data …

Rivaroxaban (Xarelto™) approved in Japan for patients with peripheral artery disease (PAD) after revascularisation Read More »

Bayer’s Vividion emerging as significant player in San Diego biotech hub

Leverkusen and San Diego, June 9, 2022 – Bayer AG and its wholly owned San Diego-based subsidiary Vividion Therapeutics, Inc. (Vividion) will highlight how the two companies have fostered innovation and collaboration through Bayer’s “arm’s length” operating model during a presentation at the 2022 BIO International Convention. Bayer has built a strong partnership with Vividion …

Bayer’s Vividion emerging as significant player in San Diego biotech hub Read More »

Bayer’s BlueRock Therapeutics establishes European site for cell therapy innovation

Berlin, June 8, 2022 – Bayer AG announced today that BlueRock Therapeutics LP (BlueRock), a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, has established a new site for cell therapy innovation on Bayer’s campus in Berlin, Germany. This move comes as part of the company’s focused growth strategy. While operating independently, the …

Bayer’s BlueRock Therapeutics establishes European site for cell therapy innovation Read More »